-
·
FDA Update: Good News for Multiple Myeloma?
Good news for multiple myeloma patients: FDA committee approves new clinical trial requirement to accelerate approvals on April 12, 2024.
-
·
The Latest in Multiple Myeloma: Understanding Promising Treatment Options
The Latest in Multiple Myeloma: Understanding Promising Treatment Options Patient advocates Cindy Chmielewski and Jack Aiello, and experts Dr. Rafael Fonseca and Dr. Susan Bal discuss promising multiple myeloma treatment options.
-
·
Multiple Myeloma Treatment | Joseph Mikhael, MD
3-drug vs. 4-drug combinations Multiple myeloma expert Dr. Joseph Mikhael discusses the use of 3-drug vs. 4-drug combinations for front-line treatment.
-
·
Multiple Myeloma Screening | Joseph Mikhael, MD
Multiple Myeloma Screening Dr. Joseph Mikhael discusses exciting advances in multiple myeloma screening, including new information from the iSTOP and PROMISE clinical trials.
-
·
Immunotherapy for Multiple Myeloma | Joseph Mikhael, MD
Emerging Therapies Dr. Joseph Mikhael discusses exciting advances in multiple myeloma treatment, including bispecifics and CAR T-cell therapy.
-
·
Multiple Myeloma Research | Moffitt Cancer Center
Deciding Best Myeloma Treatment for a Patient Using a New Strategy Focus: Possible way of determining optimal treatment for patients without them having to go through treatment first, via using new approaches of studying tumors outside the body, gene expression, and computational data.Featuring: Praneeth Sudalagunta, Ph.D, Moffitt Cancer Center
